This website uses cookies to help us give you the best browsing experience. By continuing to use this portal, you agree to our use of this tool.
To learn more about how we use cookies and how to manage them please read our notice here.
Tip of the Month
Tip of the month - In patients with chronic angle-closure glaucoma and cataract, phacoemulsification with IOL implantation usually results in IOP control up to 2 years after surgery
In patients with chronic angle-closure glaucoma and cataract, phacoemulsification with IOL implantation usually results in IOP control up to 2 years after surgery

Publishing date: June 2010

Tip Editors: Ann Hoste, John Salmon and John Thygesen
Tip reviewer: Roger Hitchings


The Science behind the Tip

An anteriorly positioned and thickened lens plays an important role in the pathogenesis of anterior chamber shallowing in primary angle-closure glaucoma(1).

In individuals with chronic angle-closure glaucoma and cataract, phacoemulsification with IOL implantation usually results in improved IOP control up to 2 years after surgery, whether the preoperative IOP is medically controlled or not(2).

The intraoperative complication rate of 5-8% is higher than usual. Less topical medication to reduce IOP is needed post-operatively. In those patients with controlled preoperative IOP who undergo phacoemulsification, 3% subsequently need a trabeculectomy, compared to 15% with uncontrolled preoperative IOP.


Contributor: J F Salmon - Oxford Eye Hospital, Oxford, UK



References

1. Tarongy P, Ho CL, Walton DS. Angle-closure: the role of the lens in pathogenesis, prevention and treatment. Surv Ophthalmol. 2009;54:211-25

2. Tham CC, Kwong YY, Leung DY et al. Phacoemulsification versus combined phacoemulsification in medically controlled chronic angle-closure glaucoma. Ophthalmology. 2008;115:2167-73.



back to top